REVANCE THERAPEUTICS INC shareholders Q1 2023

REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 220 filers reported holding REVANCE THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.25 and the average weighting 0.2%.

REVANCE THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Palo Alto Investors LP 5,270,209$169,753,43214.06%
Essex Woodlands Management, Inc. 457,085$14,722,7088.52%
Evolutionary Tree Capital Management, LLC 66,825$2,152,4332.98%
Ghost Tree Capital, LLC 250,000$8,053,0002.38%
Jericho Capital Asset Management L.P. 1,438,669$46,339,5281.92%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 183,000$5,888,9401.64%
Integral Health Asset Management, LLC 250,000$8,052,5001.62%
RICE HALL JAMES & ASSOCIATES, LLC 809,176$26,063,5591.48%
Waypoint Capital Advisors, LLC 90,989$2,929,8460.95%
Polar Capital Holdings Plc 4,167,842$134,246,1910.87%
Rhenman & Partners Asset Management AB 230,000$7,159,9000.79%
RF&L WEALTH MANAGEMENT, LLC 20,000$644,2000.62%
ESSEX INVESTMENT MANAGEMENT CO LLC 108,613$3,498,4250.51%
EAM Investors, LLC 79,905$2,573,7400.51%
HAP Trading, LLC 253,400$2,7240.43%
Jackson Creek Investment Advisors LLC 28,214$9090.38%
Caption Management, LLC 585,700$18,865,3970.36%
Alpha DNA Investment Management LLC 33,552$1,080,7090.32%
Kamunting Street Capital Management, L.P. 7,736$249,1770.32%
Kula Investments, LLC 31,545$1,016,0640.25%
External links

This page lists REVANCE THERAPEUTICS INC's shareholders in Q1 2023. To view REVANCE THERAPEUTICS INC's shareholder history, click here.